MENU

Is it too late to buy a2 Milk shares?

One of the best performers on the Australian share market over the last month has been the a2 Milk Company Ltd (ASX: A2M) share price.

During this time the infant formula and fresh milk company’s shares have put on a gain of 14%.

Why is the a2 Milk share price up 14% in a month?

Investors have been fighting to get hold of a2 Milk Company’s shares after it released a half year result that smashed the market’s expectations.

In the first half of FY 2019 the company posted a 41% increase in total revenue to NZ$613.1 million and a massive 55.1% lift in net profit after tax to NZ$152.7 million.

This strong result was underpinned by impressive growth in both the ANZ and China markets. The ANZ business segment delivered a 37.5% increase in revenue to NZ$418.4 million and a 64.9% jump in EBITDA to NZ$192 million.

Backing up this growth was its China and Other Asia segment which posted a 50.1% lift in revenue to NZ$171.7 million and a 41.6% increase in EBITDA to NZ$68.4 million.

Once again it was infant formula products that generated the most sales for the company. Infant nutrition product sales rose 45.3% to NZ$495.5 million, meaning they account for almost 81% of sales now. Liquid milk sales rose 20.2% during the half.

Is it too late to invest?

Based on management’s guidance for similar revenue growth in the second half and an EBITDA margin of 31% to 32%, I expect revenue of NZ$1.3 billion and EBITDA of ~NZ$416 million in FY 2019.

If all else remains equal, I expect this to lead to a net profit after tax of NZ$291 million and earnings per share of 41 NZ cents (39.3 AU cents). Which means that its shares are currently changing hands at 35x estimated forward earnings.

Whilst this is clearly a premium to the market average, given its current growth profile I feel this is a fair price to pay to own its shares.

I would choose them ahead of Bellamy’s Australia Ltd (ASX: BAL) and Bubs Australia Ltd (ASX: BUB) at this point.

As well as a2 Milk, I think these growth shares could be great options in March.

Top 3 ASX Blue Chips To Buy For 2019

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked...

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2019."

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!